You are here

NLG919

NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer

Yahoo

Thu, 04/4/13 - 09:35 am

NewLink Genetics

IDO pathway inhibitors